Guillain-Barré syndrome after COVID-19 vaccination: report of two cases from Vietnam

Authors

  • Pham Dang Hai Intensive Care Unit, 108 Military Central Hospital, Hanoi, Vietnam https://orcid.org/0000-0001-9300-231X
  • Le Lan Phuong Intensive Care Unit, 108 Military Central Hospital, Hanoi, Vietnam
  • Nguyen Hong Tot Intensive Care Unit, 108 Military Central Hospital, Hanoi, Vietnam https://orcid.org/0000-0002-1760-3348
  • Nguyen Le Phuong Anh University of Sydney, Australia
  • Nguyen Dinh Tung College of Health Sciences,Vin University, Vietnam
  • Nguyen Hong Quan Department of Neurology, 108 Military Central Hospital, Hanoi, Vietnam https://orcid.org/0000-0003-4857-628X

DOI:

https://doi.org/10.3855/jidc.16998

Keywords:

Guillain-Barré Syndrome, GBS, COVID-19 vaccination, plasmapheresis

Abstract

Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization in March 2020 and since then it has spread to almost every country around the world. Vaccines against COVID-19 are considered an essential measure to curb this pandemic. However, side effects, including local and systemic reactions, after administering the COVID-19 vaccine have been defined, and some side effects have been reported. We present two cases of Guillain-Barré Syndrome (GBS) after receiving the ChAdOx1 nCoV-19 vaccine (Oxford- AstraZeneca). Both cases were admitted to the 108 Military Central Hospital, Vietnam, and received plasmapheresis therapy with satisfactory recovery after treatment.

Downloads

Download data is not yet available.

Downloads

Published

2022-11-29

How to Cite

1.
Hai PD, Phuong LL, Tot NH, Anh NLP, Tung ND, Quan NH (2022) Guillain-Barré syndrome after COVID-19 vaccination: report of two cases from Vietnam. J Infect Dev Ctries 16:1703–1705. doi: 10.3855/jidc.16998

Issue

Section

Coronavirus Pandemic